Journal of Medical Economics, Volume 20, Issue 10 (2017)

Browse this journal
Sample our Medicine, Dentistry, Nursing & Allied Health journals, sign in here to start your FREE access for 14 days

Journal of Medical Economics, Volume 20, Issue 10 (2017)

See all volumes and issues
Vol 27, 2024 Vol 26, 2023 Vol 25, 2022 Vol 24, 2021 Vol 23, 2020 Vol 22, 2019 Vol 21, 2018 Volume 20, 2017 Vol 19, 2016 Vol 18, 2015 Vol 17, 2014 Vol 16, 2013 Vol 15, 2012 Vol 14, 2011 Vol 13, 2010 Vol 12, 2009 Vol 11, 2008 Vol 10, 2007 Vol 9, 2006 Vol 8, 2005 Vol 7, 2004 Vol 6, 2003 Vol 5, 2002 Vol 4, 2001 Vol 3, 2000 Vol 2, 1999 Vol 1, 1998
Download citations Download PDFs Download issue

Pharmacoeconomic Trends

Editorial
Pharmaceutical expenditure dynamics in the Balkan countries
Ana V. Pejcic & Mihajlo Jakovljevic
Pages: 1013-1017
Published online: 07 Jun 2017
First Page PreviewforPharmaceutical expenditure dynamics in the Balkan countries | Full Text | References | PDF (908.7 KB)
  • 2828 Views
  • 9 CrossRef citations
  • 0Altmetric
Free Access

Oncology

Article
Cost drivers for breast, lung, and colorectal cancer care in a commercially insured population over a 6-month episode: an economic analysis from a health plan perspective
Bhuvana Sagar, Yu Shen Lin & Liana D. Castel
Pages: 1018-1023
Published online: 03 Jul 2017
AbstractforCost drivers for breast, lung, and colorectal cancer care in a commercially insured population over a 6-month episode: an economic analysis from a health plan perspective | Full Text | References | PDF (774 KB)
  • 1198 Views
  • 13 CrossRef citations
  • 0Altmetric
Free Access

Diabetes

Article
Cost-effectiveness of dedicated dietitians for hyperphosphatemia management among hemodialysis patients in Lebanon: results from the Nutrition Education for Management of Osteodystrophy trial
Rana Rizk, Mickaël Hiligsmann, Mirey Karavetian & Silvia M. A. A. Evers
Pages: 1024-1038
Published online: 13 Jul 2017
AbstractforCost-effectiveness of dedicated dietitians for hyperphosphatemia management among hemodialysis patients in Lebanon: results from the Nutrition Education for Management of Osteodystrophy trial | Full Text | References | PDF (2.8 MB)
  • 953 Views
  • 5 CrossRef citations
  • 0Altmetric
Free Access

Psychiatry

Article
Cost-effectiveness of 3-month paliperidone treatment for chronic schizophrenia in Spain
Thomas R. Einarson, Basil G. Bereza, Ignacio Garcia Llinares, Beatriz González Martín Moro, Fadi Tedouri & Kristel Van Impe
Pages: 1039-1047
Published online: 13 Jul 2017
AbstractforCost-effectiveness of 3-month paliperidone treatment for chronic schizophrenia in Spain | Full Text | References | PDF (3.1 MB)
  • 1504 Views
  • 16 CrossRef citations
  • 0Altmetric
Free Access

Immunology

Article
Economic burden of sarcoidosis in a commercially-insured population in the United States
J. Bradford Rice, Alan White, Andrea Lopez, Alexandra Conway, Aneesha Wagh, Winnie W. Nelson, Michael Philbin & George J. Wan
Pages: 1048-1055
Published online: 21 Jul 2017
AbstractforEconomic burden of sarcoidosis in a commercially-insured population in the United States | Full Text | References | PDF (891.8 KB)
  • 1065 Views
  • 29 CrossRef citations
  • 0Altmetric
Free Access

Neurology

Article
Cost-effectiveness analysis of ocrelizumab versus subcutaneous interferon beta-1a for the treatment of relapsing multiple sclerosis
Hongbo Yang, Emilie Duchesneau, Rebekah Foster, Annie Guerin, Esprit Ma & Nina P. Thomas
Pages: 1056-1065
Published online: 31 Jul 2017
AbstractforCost-effectiveness analysis of ocrelizumab versus subcutaneous interferon beta-1a for the treatment of relapsing multiple sclerosis | Full Text | References | PDF (1.2 MB) | Supplemental
  • 3270 Views
  • 21 CrossRef citations
  • 0Altmetric
Free Access

Oncology

Article
Impact of novel agents on patient-relevant outcomes in patients with previously untreated chronic lymphocytic leukemia who are not eligible for fludarabine-based therapy
Moushmi Singh, Stuart Mealing, Simona Baculea, Sarah Cote & Jo Whelan
Pages: 1066-1073
Published online: 09 Aug 2017
AbstractforImpact of novel agents on patient-relevant outcomes in patients with previously untreated chronic lymphocytic leukemia who are not eligible for fludarabine-based therapy | Full Text | References | PDF (1.2 MB)
  • 832 Views
  • 4 CrossRef citations
  • 0Altmetric
Free Access

Neurology

Article
Incremental net monetary benefit of ocrelizumab relative to subcutaneous interferon β-1a
Melissa A. Frasco, Tiffany Shih, Devin Incerti, Oliver Diaz Espinosa, Diana K. Vania & Nina Thomas
Pages: 1074-1082
Published online: 04 Aug 2017
AbstractforIncremental net monetary benefit of ocrelizumab relative to subcutaneous interferon β-1a | Full Text | References | PDF (1.3 MB)
  • 1652 Views
  • 13 CrossRef citations
  • 0Altmetric
Free Access

Oncology

Article
Cost-efficiency analyses for the US of biosimilar filgrastim-sndz, reference filgrastim, pegfilgrastim, and pegfilgrastim with on-body injector in the prophylaxis of chemotherapy-induced (febrile) neutropenia
Ali McBride, Kim Campbell, Mohan Bikkina, Karen MacDonald, Ivo Abraham & Sanjeev Balu
Pages: 1083-1093
Published online: 04 Aug 2017
AbstractforCost-efficiency analyses for the US of biosimilar filgrastim-sndz, reference filgrastim, pegfilgrastim, and pegfilgrastim with on-body injector in the prophylaxis of chemotherapy-induced (febrile) neutropenia | Full Text | References | PDF (1.6 MB) | Supplemental
  • 1893 Views
  • 29 CrossRef citations
  • 0Altmetric
Free Access

Infectious Disease

Review
Economic evaluations of Haemophilus influenzae type b (Hib) vaccine: a systematic review
Bunchai Chongmelaxme, Maythika Hammanee, Wariya Phooaphirak, Surachai Kotirum, Raymond Hutubessy & Nathorn Chaiyakunapruk
Pages: 1094-1106
Published online: 04 Aug 2017
AbstractforEconomic evaluations of Haemophilus influenzae type b (Hib) vaccine: a systematic review | Full Text | References | PDF (1.1 MB) | Supplemental
  • 1710 Views
  • 6 CrossRef citations
  • 0Altmetric
Free Access

Pharmacoeconomic Trends

Article Commentary
The importance of model inputs and assumptions in conducting health technology assessments of novel drugs
Tomas Philipson & Joanna P. MacEwan
Pages: 1107-1109
Published online: 04 Aug 2017
First Page PreviewforThe importance of model inputs and assumptions in conducting health technology assessments of novel drugs | Full Text | References | PDF (310.6 KB)
  • 392 Views
  • 0 CrossRef citations
  • 0Altmetric
Free Access

Endocrinology

Article
Exploring the potential value of improved care for secondary hyperparathyroidism with a novel calcimimetic therapy
Björn Stollenwerk, Sergio Iannazzo, Kerry Cooper & Vasily Belozeroff
Pages: 1110-1115
Published online: 14 Aug 2017
AbstractforExploring the potential value of improved care for secondary hyperparathyroidism with a novel calcimimetic therapy | Full Text | References | PDF (657 KB)
  • 1975 Views
  • 6 CrossRef citations
  • 0Altmetric
Free Access

Explore articles